Cargando…
Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension
Pulmonary arterial hypertension is a fatal disease. Intravenous prostanoids are often utilized for long-term management of patients. The therapy requires a significant commitment and change in lifestyle for both the patient and family. Takotsubo cardiomyopathy, transient apical ballooning syndrome,...
Autores principales: | Cork, David P., Mehrotra, Amit K., Gomberg-Maitland, Mardi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487309/ https://www.ncbi.nlm.nih.gov/pubmed/23130109 http://dx.doi.org/10.4103/2045-8932.101659 |
Ejemplares similares
-
Author's reply
por: Cork, David P., et al.
Publicado: (2013) -
Rare etiological causes of Takotsubo cardiomyopathy Regarding “Takotsubo cardiomyopathy after treatment of pulmonary arterial hypertension”
por: Kapoor, Shailendra
Publicado: (2013) -
Quality of Life, Safety and Efficacy Profile of Thermostable Flolan in Pulmonary Arterial Hypertension
por: Provencher, Steeve, et al.
Publicado: (2015) -
Implantable system for treprostinil and lung transplantation: case series from delivery for pulmonary arterial hypertension study
por: Feldman, Jeremy P., et al.
Publicado: (2021) -
Right Heart Catheterization—To Do or Not To Do? Introducing a New Diagnostic Algorithm for Pulmonary Hypertension
por: Ryan, John J., et al.
Publicado: (2022)